absorption of the antiarrhythmic agent mexiletine from conventional capsules ( 200 mg ) and two sustained-release formulations ( 360 and 432 mg ) was studied in four healthy volunteer subjects , and use of the 360-mg preparation was studied in nine patients who had been using conventional capsules .
C0003195
antiarrhythmic agent
C0025887
mexiletine